Visceral Leishmaniasis-Malaria Coinfection and Their Associated Factors in Patients Attending Metema Hospital, Northwest Ethiopia: Suggestion for Integrated Vector Management.

Q2 Medicine

Malaria Research and Treatment Pub Date : 2017-01-01 Epub Date: 2017-08-28 DOI:10.1155/2017/6816913

Getachew Ferede, Ermias Diro, Sisay Getie, Gebeyaw Getnet, Yegnasew Takele, Anteneh Amsalu, Yitayih Wondimeneh

{"title":"Visceral Leishmaniasis-Malaria Coinfection and Their Associated Factors in Patients Attending Metema Hospital, Northwest Ethiopia: Suggestion for Integrated Vector Management.","authors":"Getachew Ferede, Ermias Diro, Sisay Getie, Gebeyaw Getnet, Yegnasew Takele, Anteneh Amsalu, Yitayih Wondimeneh","doi":"10.1155/2017/6816913","DOIUrl":null,"url":null,"abstract":"Background: Despite high prevalence of visceral leishmaniasis and malaria in the study area, their coinfection remains unknown. Therefore, this study was aimed to document VL-malaria coinfections and their associated factors.Methods: A cross-sectional study was conducted among clinical suspected VL patients attending Metema hospital, Northwest Ethiopia, from January 2014 to June 2014. Blood sample was tested by rk39 antigen-based DiaMed IT-Leish dipstick and Giemsa stain microscopic examination of thick and thin blood smears for malaria detection was performed.Result: A total of 384 VL suspected patients were included in the study. Out of these, the prevalence of VL was 83 (21.6%) while the prevalence of malaria was 45 (11.7%). Of malaria cases, 40 (89%) were positive for P. falciparum and 5 (11%) positive for P. vivax. The overall prevalence of VL-malaria coinfection was 16 (4.2%). One-hundred eighty (46.9%) study participants have history of travel. Of these, 10 (5.6%) have VL-malaria coinfections. Age less than 5 years was associated with VL-malaria coinfection.Conclusion: This study highlights the importance of performing malaria screening amongst VL patients living in malaria-endemic areas, particularly in patients under five years.","PeriodicalId":18089,"journal":{"name":"Malaria Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592390/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaria Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2017/6816913","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/8/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Despite high prevalence of visceral leishmaniasis and malaria in the study area, their coinfection remains unknown. Therefore, this study was aimed to document VL-malaria coinfections and their associated factors.

Methods: A cross-sectional study was conducted among clinical suspected VL patients attending Metema hospital, Northwest Ethiopia, from January 2014 to June 2014. Blood sample was tested by rk39 antigen-based DiaMed IT-Leish dipstick and Giemsa stain microscopic examination of thick and thin blood smears for malaria detection was performed.

Result: A total of 384 VL suspected patients were included in the study. Out of these, the prevalence of VL was 83 (21.6%) while the prevalence of malaria was 45 (11.7%). Of malaria cases, 40 (89%) were positive for P. falciparum and 5 (11%) positive for P. vivax. The overall prevalence of VL-malaria coinfection was 16 (4.2%). One-hundred eighty (46.9%) study participants have history of travel. Of these, 10 (5.6%) have VL-malaria coinfections. Age less than 5 years was associated with VL-malaria coinfection.

Conclusion: This study highlights the importance of performing malaria screening amongst VL patients living in malaria-endemic areas, particularly in patients under five years.

Abstract Image

查看原文本刊更多论文

埃塞俄比亚西北部 Metema 医院就诊患者的内脏利什曼病-疟疾合并感染及其相关因素：病媒综合管理建议。

背景：尽管研究地区的内脏利什曼病和疟疾发病率很高，但它们的合并感染仍不为人知。因此，本研究旨在记录内脏利什曼病与疟疾的合并感染及其相关因素：2014年1月至2014年6月，在埃塞俄比亚西北部梅特马医院就诊的临床疑似VL患者中开展了一项横断面研究。采用基于rk39抗原的DiaMed IT-Leish滴度计检测血样，并在显微镜下对浓血涂片和薄血涂片进行吉氏染色，以检测疟疾：研究共纳入了 384 名疑似 VL 患者。结果：研究共纳入 384 名 VL 疑似患者，其中 VL 患病率为 83 人（21.6%），疟疾患病率为 45 人（11.7%）。在疟疾病例中，40 例（89%）对恶性疟原虫呈阳性反应，5 例（11%）对间日疟原虫呈阳性反应。VL-疟疾合并感染的总发病率为 16 例（4.2%）。180名研究参与者（46.9%）有旅行史。其中 10 人（5.6%）患有 VL-疟疾合并感染。年龄小于 5 岁与 VL-Malaria 合并感染有关：本研究强调了对生活在疟疾流行地区的 VL 患者进行疟疾筛查的重要性，尤其是对 5 岁以下的患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Malaria Research and Treatment Medicine-Infectious Diseases

CiteScore

5.20

自引率

0.00%

发文量

期刊介绍： Malaria Research and Treatment is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to all aspects of malaria.